SCHEMBL29610440

SCHEMBL29610440

O=C1CCC(N2C(=O)c3ccc(C4CCN(Cc5cccc(S(=O)(=O)N6CCOCC6)c5)CC4)c4cccc2c34)C(=O)N1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IKZF1 Q13422 4/20 0.47
IKZF2 Q9UKS7 4/20 0.45
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
DDB1 Q16531 6/20 0.40
CRBN Q96SW2 6/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TNF P01375 3/20 0.39
IL1B P01584 3/20 0.39
IKZF3 Q9UKT9 2/20 0.39
TSHR P16473 1/20 0.38
BCL2L11 O43521 1/20 0.37
BCL2 P10415 1/20 0.37
MCL1 Q07820 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24315897 1.00 IKZF1 (0.47) IKZF1IKZF2ALDH1A1MAPTDDB1
SCHEMBL24315706 0.89 IKZF1 (0.45) IKZF1IKZF2ALDH1A1MAPTDDB1
SCHEMBL29532335 0.89 IKZF1 (0.45) IKZF1IKZF2ALDH1A1MAPTDDB1
SCHEMBL24316071 0.85 IKZF2 (0.46) IKZF1IKZF2DDB1CRBNTNF
SCHEMBL29610888 0.85 IKZF2 (0.60) IKZF1IKZF2ALDH1A1DDB1CRBN
SCHEMBL24315904 0.85 IKZF2 (0.60) IKZF1IKZF2ALDH1A1DDB1CRBN
SCHEMBL29611007 0.82 IKZF2 (0.46) IKZF1IKZF2DDB1CRBNTNF
SCHEMBL24315907 0.82 IKZF2 (0.46) IKZF1IKZF2DDB1CRBNTNF
SCHEMBL24315890 0.81 IKZF2 (0.55) IKZF1IKZF2ALDH1A1DDB1CRBN
SCHEMBL29611545 0.81 IKZF2 (0.55) IKZF1IKZF2ALDH1A1DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4228639-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 Therapeutics, Inc. (US) 2023-08-23 EP disclosed
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed